Literature DB >> 2534521

Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action.

E Tatarczyńska1, E Chojnacka-Wójcik.   

Abstract

8-OH-DPAT and ipsapirone were studied in rats and mice in the tests used for preclinical assessment of antidepressant activity, 8-OH-DPAT shortened the immobility time in the behavioral despair test in rats and mice and counteracted the hypothermia induced by reserpine or apomorphine, whereas ipsapirone revealed only a weak activity in the despair test in rats but not in mice, and was inactive in the hypothermia induced by reserpine or apomorphine. The antireserpine action of 8-OH-DPAT was reduced by haloperidol and also by ipsapirone less potently, though. The obtained results indicate that 8-OH-DPAT acts similarly to typical antidepressants in behavioral tests regarded as specific, whereas ipsapirone is devoid of such an action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534521

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  4 in total

1.  1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.

Authors:  P Martin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.

Authors:  V Klimek; J Zak-Knapik; M Mackowiak
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

3.  Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after repeated administration on a conditioned avoidance response (CAR) in the rat.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists.

Authors:  M J Detke; S Wieland; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.